HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity

被引:14
|
作者
Suzuki, Kazuo [1 ]
Levert, Angelique [1 ]
Yeung, Julie [1 ]
Starr, Mitchell [1 ]
Cameron, Jane [1 ]
Williams, Raffaella [1 ]
Rismanto, Nikolas [1 ]
Stark, Tayla [1 ]
Druery, Dylan [1 ]
Prasad, Salzeena [1 ]
Ferrarini, Cristina [1 ]
Hanafi, Imelda [1 ]
McNally, Leon Patrick [1 ]
Cunningham, Philip [1 ]
Liu, Zhixin [2 ]
Ishida, Takaomi [3 ]
Huang, Chin-Shiou [4 ]
Oswald, Velma [5 ]
Evans, Louise [5 ,6 ]
Symonds, Geoffrey [7 ]
Brew, Bruce James [8 ,9 ,10 ,11 ,12 ,13 ]
Zaunders, John [1 ]
机构
[1] St Vincents Ctr Appl Med Res, NSW State Reference Lab HIV, Sydney, NSW, Australia
[2] Univ New South Wales, Stats Cent, Sydney, NSW, Australia
[3] Denka Co Ltd, Tokyo, Japan
[4] PlexBio Co Ltd, Taipei, Taiwan
[5] Liverpool Hosp, Clin Immunol & HIV Med, Sydney, NSW, Australia
[6] Univ New South Wales, Sydney, NSW, Australia
[7] CSL Biotechnol, Sydney, NSW, Australia
[8] St Vincents Ctr Appl Med Res, Dept Neurol, Sydney, NSW, Australia
[9] St Vincents Ctr Appl Med Res, Dept Immunol, Sydney, NSW, Australia
[10] St Vincents Ctr Appl Med Res, Peter Duncan Neurosci Unit, Sydney, NSW, Australia
[11] Univ Notre Dame, Sydney, NSW, Australia
[12] St Vincents Hosp, Dept HIV Med, Sydney, NSW, Australia
[13] Univ New South Wales, St Vincents Clin Sch, Delacy Bldg, Sydney, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
activation of CD4(+) T cells; blip episode; HIV reservoir; HIV-1; transcriptional activity; CD4(+) T-CELLS; ANTIRETROVIRAL THERAPY; PERIPHERAL-BLOOD; DRUG-RESISTANCE; ASSAY; RESERVOIR; VIREMIA; ACTIVATION; QUANTIFICATION; SUPPRESSION;
D O I
10.1097/QAD.0000000000003001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: Some HIV+ patients, virally suppressed on ART, show occasional 'blips' of detectable HIV-1 plasma RNA. We used a new highly sensitive assay of cell-associated HIV-1 RNA to measure transcriptional activity in PBMCs and production of infectious virus from the viral reservoir, in patients with and without 'blips'. Design/methods: RNA and DNA extracted from cells in 6ml of peripheral blood, from suppressed patients with one to two 'blip' episodes over the past 2 years of ART (n = 55), or no 'blips' (n = 52), were assayed for HIV-1 RNA transcripts and proviral DNA targeting the highly conserved 'R' region of the LTR. Follow- up samples were also collected. Purified CD4(+) T cells were cultured with anti-CD3/CD28/ CD2 T- cell activator to amplify transcription and measure replication competent virus. Results: HIV- 1 RNA transcripts ranged from 1.3 to 5415 copies/10(6) white blood cells. 'Blip' patients had significantly higher levels vs. without blips (median 192 vs. 49; P = 0.0007), which correlated with: higher levels of inducible transcripts after activation in vitro, sustained higher HIV-1 transcription levels in follow-up samples along with increasing HIV-1 DNA in some, and production of replication-competent HIV-1. Conclusion: Viral 'blips' are significant reflecting higher transcriptional activity from the reservoir and contribute to the reservoir over time. This sensitive assay can be used in monitoring the size and activity of the HIV-1 reservoir and will be useful in HIV-1 cure strategies. Copyright (C) 2021 The Author(s). Published by Wolters Kluwer Health, Inc.
引用
收藏
页码:2095 / 2103
页数:9
相关论文
共 50 条
  • [1] Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
    Erik Sörstedt
    Staffan Nilsson
    Anders Blaxhult
    Magnus Gisslén
    Leo Flamholc
    Anders Sönnerborg
    Aylin Yilmaz
    BMC Infectious Diseases, 16
  • [2] Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
    Sorstedt, Erik
    Nilsson, Staffan
    Blaxhult, Anders
    Gisslen, Magnus
    Flamholc, Leo
    Sonnerborg, Anders
    Yilmaz, Aylin
    BMC INFECTIOUS DISEASES, 2016, 16
  • [3] Shifts in cell-associated HIV-1 RNA but not in episomal HIV-1 DNA correlate with new cycles of HIV-1 infection in vivo
    Fischer, M
    Trkola, A
    Joos, B
    Hafner, R
    Joller, H
    Muesing, MA
    Kaufman, DR
    Berli, E
    Hirschel, B
    Weber, R
    Günthard, HF
    ANTIVIRAL THERAPY, 2003, 8 (02) : 97 - 104
  • [4] Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
    Gianella, Sara
    von Wyl, Viktor
    Fischer, Marek
    Niederoest, Barbara
    Battegay, Manuel
    Bernasconi, Enos
    Cavassini, Matthias
    Rauch, Andri
    Hirschel, Bernard
    Vernazza, Pietro
    Weber, Rainer
    Joos, Beda
    Guenthard, Huldrych F.
    ANTIVIRAL THERAPY, 2011, 16 (04) : 535 - 545
  • [5] HIV-1 concentrates and shelters cell-associated infectivity a "viral biofilm"
    Inizan, C.
    Derames, A.
    Caillet, M.
    David, A.
    Versmisse, P.
    Saez-Cirion, A.
    Mesel-Lemoine, M.
    Mallet, A.
    Sachse, M.
    Mouquet, H.
    Boufassa, F.
    Lambotte, O.
    Bourdic, K.
    Thoulouze, M-I
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20 : 48 - 49
  • [6] Update on HIV-1 viral load blips
    Nettles, Richard E.
    Kieffer, Tara L.
    CURRENT OPINION IN HIV AND AIDS, 2006, 1 (02) : 157 - 161
  • [7] Inhibition of cell-associated HIV-1 by silver nanoparticles
    Singh, Dinesh K.
    Lara, Humberto H.
    RETROVIROLOGY, 2012, 9
  • [8] Inhibition of cell-associated HIV-1 by silver nanoparticles
    Dinesh K Singh
    Humberto H Lara
    Retrovirology, 9
  • [9] Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA
    Hong, Feiyu
    Aga, Evgenia
    Cillo, Anthony R.
    Yates, Aarika L.
    Besson, Guillaume
    Fyne, Elizabeth
    Koontz, Dianna L.
    Jennings, Cheryl
    Zheng, Lu
    Mellors, John W.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (04) : 902 - 911
  • [10] Rectal cell-associated HIV-1 RNA as a marker for trials targeting the reservoir
    Lafeuillade, A.
    Cheret, A.
    Hittinger, G.
    Bernardini, D.
    Cuquemelle, C.
    Jullian, E.
    Poggi, C.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A102 - A102